Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000252691 (LOC124900433) is annotated as a small Cajal body-specific RNA gene (scaRNA gene), a subclass of non-coding RNAs likely involved in post-transcriptional RNA modification within the Cajal bodies of the nucleus. It is not a protein-coding gene and does not have a direct role as a receptor, enzyme, transporter, or other canonical drug target[1]. No functional or disease data are available, and it is not documented as being involved in human pathology or pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Cajal body-specific RNA gene (scaRNA gene) (ENSG00000252691).